These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4029512)

  • 1. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1985 Sep; 34(9):938-41. PubMed ID: 4029512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties.
    Gonen B; Baenziger J; Schonfeld G; Jacobson D; Farrar P
    Diabetes; 1981 Oct; 30(10):875-8. PubMed ID: 7274589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nonenzymatic glycosylation in atherogenesis.
    Cerami A; Vlassara H; Brownlee M
    J Cell Biochem; 1986; 30(2):111-20. PubMed ID: 3517022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
    Brownlee M; Vlassara H; Cerami A
    Ann Intern Med; 1984 Oct; 101(4):527-37. PubMed ID: 6383165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
    Lyons TJ
    Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity.
    Witztum JL; Mahoney EM; Branks MJ; Fisher M; Elam R; Steinberg D
    Diabetes; 1982 Apr; 31(4 Pt 1):283-91. PubMed ID: 6818075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of arterial collagen nonenzymatic glycosylation (NEG) in the pathogenesis of diabetic macroangiopathy].
    Fu M; Qian R
    Zhonghua Yi Xue Za Zhi; 1991 Apr; 71(4):202-4, 14. PubMed ID: 1650631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation.
    Howard EW; Benton R; Ahern-Moore J; Tomasek JJ
    Exp Cell Res; 1996 Oct; 228(1):132-7. PubMed ID: 8892980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells.
    Crowley ST; Brownlee M; Edelstein D; Satriano JA; Mori T; Singhal PC; Schlondorff DO
    Diabetes; 1991 May; 40(5):540-7. PubMed ID: 1708734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.
    Hunt JV; Bottoms MA; Clare K; Skamarauskas JT; Mitchinson MJ
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):243-9. PubMed ID: 8198540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of low density lipoprotein--collagen interaction.
    Eskenasy M; Mora R; Simionescu N
    Morphol Embryol (Bucur); 1984; 30(2):147-52. PubMed ID: 6234461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
    Hodgkinson CP; Laxton RC; Patel K; Ye S
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat.
    Shires TK; Faeth JA; Pulido JS
    Retina; 1990; 10(2):153-8. PubMed ID: 2144905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications.
    Vlassara H; Brownlee M; Cerami A
    Clin Chem; 1986 Oct; 32(10 Suppl):B37-41. PubMed ID: 3530538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose.
    Hunt JV; Smith CC; Wolff SP
    Diabetes; 1990 Nov; 39(11):1420-4. PubMed ID: 2227114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
    Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
    Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.
    Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T
    Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of LDL and modified LDL with mesangial cells and matrix.
    Gupta S; Rifici V; Crowley S; Brownlee M; Shan Z; Schlondorff D
    Kidney Int; 1992 May; 41(5):1161-9. PubMed ID: 1614032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-enzymic glycation of collagen inhibits binding of oxidized low-density lipoprotein.
    Kalant N; McCormick S; Parniak MA
    Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):661-6. PubMed ID: 8352733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen aging in vitro by nonenzymatic glycosylation and browning.
    Kohn RR; Cerami A; Monnier VM
    Diabetes; 1984 Jan; 33(1):57-9. PubMed ID: 6418598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.